ARTICLE | Company News
Xencor, J&J deal
January 21, 2013 8:00 AM UTC
Xencor received an undisclosed milestone payment from Johnson & Johnson's Janssen Research & Development LLC subsidiary under a 2009 deal granting the pharma rights to use Xencor's XmAb and Xtend tech...